An allogeneic anti-cancer effect after hematopoietic stem cell transplantation.
Center for Allogeneic Stem Cell Transplantation, Huddinge University Hospital, Stockholm, Sweden.
L
L
Barkholt
P
P
Hentschke
H
H
Zetterquist
J
J
Mattsson
M
M
Uzunel
P
P
Wersäll
J
J
Martola
N
N
Albin
J
J
Aschan
H
H
Wijkström
A
A
Tillegård
S
S
Oman
A
A
Wernerson
D
D
Niederwieser
A
A
Thörne
O
O
Ringdén
D000368:Aged; D014408:Biomarkers, Tumor / Q000097:blood; D003110:Colonic Neoplasms / Q000097:blood / Q000601:surgery / Q000628:therapy*; D005260:Female; D006086:Graft vs Host Disease; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D007680:Kidney Neoplasms / Q000097:blood / Q000601:surgery / Q000628:therapy*; D008297:Male; D008875:Middle Aged; D019172:Transplantation Conditioning; D014184:Transplantation, Homologous
D014408:Biomarkers, Tumor